As of 2025-07-14, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -118.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 13,739.84 mil USD. ITCI's TTM EBITDA according to its financial statements is -116.21 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 13.1x | 10.8x |
| Forward P/E multiples | 11.4x - 17.6x | 15.0x |
| Fair Price | (9.51) - (11.37) | (11.19) |
| Upside | -107.2% - -108.6% | -108.5% |
| Date | EV/EBITDA |